{
    "title": "Endo profit, sales beat as the drugmaker enters transition phase",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4267476/Generic-drugmaker-Endos-profit-revenue-beat-estimates.html",
    "date": "2017-02-28",
    "keywords": [
        "revenue",
        "profit",
        "ceo",
        "campanelli",
        "business",
        "endo",
        "paul",
        "year",
        "drugmaker",
        "growth",
        "drug",
        "quarter",
        "unit",
        "groverfeb",
        "beat",
        "period",
        "transitionwith",
        "pricing",
        "margin",
        "conference",
        "callthe",
        "dublin",
        "percent",
        "morning",
        "trading",
        "company",
        "blair",
        "path",
        "forward",
        "erosion",
        "base",
        "product",
        "launchescampanelli",
        "september",
        "debt",
        "load",
        "mounting",
        "pressure",
        "management",
        "spent",
        "ascension",
        "helm",
        "core",
        "injection",
        "month",
        "restructuring",
        "program",
        "belbuca",
        "incendo",
        "tuesday",
        "south",
        "healthcare",
        "group",
        "process",
        "sale",
        "somar",
        "street",
        "launch",
        "quetiapine",
        "cholesterol",
        "treatment",
        "ezetimibe",
        "demand",
        "projection",
        "legacy",
        "businessendo",
        "share",
        "impact",
        "tax",
        "rate",
        "forecast",
        "conservatism",
        "question",
        "rbc",
        "stanicky",
        "client",
        "loss",
        "attributable",
        "asset",
        "charge",
        "reporting",
        "grover",
        "bengaluru",
        "editing",
        "dcouto"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}